Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-EN Version v13-EN
Language English English
Date Updated 2019-05-11 2019-05-10
Drug Identification Number 02285606 02285606
Brand name ALVESCO ALVESCO
Common or Proper name ciclesonide ciclesonide
Company Name ASTRAZENECA CANADA INC ASTRAZENECA CANADA INC
Ingredients CICLESONIDE CICLESONIDE
Strength(s) 100MCG 100MCG
Dosage form(s) AEROSOL, METERED DOSE AEROSOL, METERED DOSE
Route of administration INHALATION INHALATION
Packaging size 120 doses 120 doses
ATC code R03BA R03BA
ATC description OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2019-04-18 2019-04-18
Actual start date 2019-04-18 2019-04-18
Estimated end date 2019-05-09 2019-05-09
Actual end date 2019-05-10 2019-05-10
Shortage status Resolved Actual shortage
Company comments Manufacturing capacity constraints Manufacturing capacity constraints
Health Canada comments